Artificial Organs-United States Market Status and Trend Report 2013-2023
Report Summary
Artificial Organs-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Artificial Organs industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Artificial Organs 2013-2017, and development forecast 2018-2023
Main market players of Artificial Organs in United States, with company and product introduction, position in the Artificial Organs market
Market status and development trend of Artificial Organs by types and applications
Cost and profit status of Artificial Organs, and marketing status
Market growth drivers and challenges
The report segments the United States Artificial Organs market as:
United States Artificial Organs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Artificial Organs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Artificial Heart
Artificial Liver
Artificial Pancreas
Artificial Lungs
Artificial Kidney
Other
United States Artificial Organs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Other
United States Artificial Organs Market: Players Segment Analysis (Company and Product introduction, Artificial Organs Sales Volume, Revenue, Price and Gross Margin):
Abbott Diabetes Care, Inc.
Abiomed, Inc.
Asahi Kasei Medical Co., Ltd.
Baxter International, Inc.
F.Hoffmann-La Roche Ltd.
Fresenius Medical Care AG & Co. KGaA
HeartWare International, Inc.
Jarvik Heart, Inc.
Medtronic, Inc.
Nikkiso Co., Ltd.
Nipro Corporation
SynCardia Systems, Inc.
Terumo Heart, Inc.
Thoratec Corp.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Artificial Organs-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Artificial Organs industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Artificial Organs 2013-2017, and development forecast 2018-2023
Main market players of Artificial Organs in United States, with company and product introduction, position in the Artificial Organs market
Market status and development trend of Artificial Organs by types and applications
Cost and profit status of Artificial Organs, and marketing status
Market growth drivers and challenges
The report segments the United States Artificial Organs market as:
United States Artificial Organs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Artificial Organs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Artificial Heart
Artificial Liver
Artificial Pancreas
Artificial Lungs
Artificial Kidney
Other
United States Artificial Organs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Other
United States Artificial Organs Market: Players Segment Analysis (Company and Product introduction, Artificial Organs Sales Volume, Revenue, Price and Gross Margin):
Abbott Diabetes Care, Inc.
Abiomed, Inc.
Asahi Kasei Medical Co., Ltd.
Baxter International, Inc.
F.Hoffmann-La Roche Ltd.
Fresenius Medical Care AG & Co. KGaA
HeartWare International, Inc.
Jarvik Heart, Inc.
Medtronic, Inc.
Nikkiso Co., Ltd.
Nipro Corporation
SynCardia Systems, Inc.
Terumo Heart, Inc.
Thoratec Corp.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ARTIFICIAL ORGANS
1.1 Definition of Artificial Organs in This Report
1.2 Commercial Types of Artificial Organs
1.2.1 Artificial Heart
1.2.2 Artificial Liver
1.2.3 Artificial Pancreas
1.2.4 Artificial Lungs
1.2.5 Artificial Kidney
1.2.6 Other
1.3 Downstream Application of Artificial Organs
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Other
1.4 Development History of Artificial Organs
1.5 Market Status and Trend of Artificial Organs 2013-2023
1.5.1 United States Artificial Organs Market Status and Trend 2013-2023
1.5.2 Regional Artificial Organs Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Artificial Organs in United States 2013-2017
2.2 Consumption Market of Artificial Organs in United States by Regions
2.2.1 Consumption Volume of Artificial Organs in United States by Regions
2.2.2 Revenue of Artificial Organs in United States by Regions
2.3 Market Analysis of Artificial Organs in United States by Regions
2.3.1 Market Analysis of Artificial Organs in New England 2013-2017
2.3.2 Market Analysis of Artificial Organs in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Artificial Organs in The Midwest 2013-2017
2.3.4 Market Analysis of Artificial Organs in The West 2013-2017
2.3.5 Market Analysis of Artificial Organs in The South 2013-2017
2.3.6 Market Analysis of Artificial Organs in Southwest 2013-2017
2.4 Market Development Forecast of Artificial Organs in United States 2018-2023
2.4.1 Market Development Forecast of Artificial Organs in United States 2018-2023
2.4.2 Market Development Forecast of Artificial Organs by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Artificial Organs in United States by Types
3.1.2 Revenue of Artificial Organs in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Artificial Organs in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Artificial Organs in United States by Downstream Industry
4.2 Demand Volume of Artificial Organs by Downstream Industry in Major Countries
4.2.1 Demand Volume of Artificial Organs by Downstream Industry in New England
4.2.2 Demand Volume of Artificial Organs by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Artificial Organs by Downstream Industry in The Midwest
4.2.4 Demand Volume of Artificial Organs by Downstream Industry in The West
4.2.5 Demand Volume of Artificial Organs by Downstream Industry in The South
4.2.6 Demand Volume of Artificial Organs by Downstream Industry in Southwest
4.3 Market Forecast of Artificial Organs in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ARTIFICIAL ORGANS
5.1 United States Economy Situation and Trend Overview
5.2 Artificial Organs Downstream Industry Situation and Trend Overview
CHAPTER 6 ARTIFICIAL ORGANS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Artificial Organs in United States by Major Players
6.2 Revenue of Artificial Organs in United States by Major Players
6.3 Basic Information of Artificial Organs by Major Players
6.3.1 Headquarters Location and Established Time of Artificial Organs Major Players
6.3.2 Employees and Revenue Level of Artificial Organs Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ARTIFICIAL ORGANS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Diabetes Care, Inc.
7.1.1 Company profile
7.1.2 Representative Artificial Organs Product
7.1.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Abbott Diabetes Care, Inc.
7.2 Abiomed, Inc.
7.2.1 Company profile
7.2.2 Representative Artificial Organs Product
7.2.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Abiomed, Inc.
7.3 Asahi Kasei Medical Co., Ltd.
7.3.1 Company profile
7.3.2 Representative Artificial Organs Product
7.3.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Asahi Kasei Medical Co., Ltd.
7.4 Baxter International, Inc.
7.4.1 Company profile
7.4.2 Representative Artificial Organs Product
7.4.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Baxter International, Inc.
7.5 F.Hoffmann-La Roche Ltd.
7.5.1 Company profile
7.5.2 Representative Artificial Organs Product
7.5.3 Artificial Organs Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche Ltd.
7.6 Fresenius Medical Care AG & Co. KGaA
7.6.1 Company profile
7.6.2 Representative Artificial Organs Product
7.6.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Fresenius Medical Care AG & Co. KGaA
7.7 HeartWare International, Inc.
7.7.1 Company profile
7.7.2 Representative Artificial Organs Product
7.7.3 Artificial Organs Sales, Revenue, Price and Gross Margin of HeartWare International, Inc.
7.8 Jarvik Heart, Inc.
7.8.1 Company profile
7.8.2 Representative Artificial Organs Product
7.8.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Jarvik Heart, Inc.
7.9 Medtronic, Inc.
7.9.1 Company profile
7.9.2 Representative Artificial Organs Product
7.9.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Medtronic, Inc.
7.10 Nikkiso Co., Ltd.
7.10.1 Company profile
7.10.2 Representative Artificial Organs Product
7.10.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Nikkiso Co., Ltd.
7.11 Nipro Corporation
7.11.1 Company profile
7.11.2 Representative Artificial Organs Product
7.11.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Nipro Corporation
7.12 SynCardia Systems, Inc.
7.12.1 Company profile
7.12.2 Representative Artificial Organs Product
7.12.3 Artificial Organs Sales, Revenue, Price and Gross Margin of SynCardia Systems, Inc.
7.13 Terumo Heart, Inc.
7.13.1 Company profile
7.13.2 Representative Artificial Organs Product
7.13.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Terumo Heart, Inc.
7.14 Thoratec Corp.
7.14.1 Company profile
7.14.2 Representative Artificial Organs Product
7.14.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Thoratec Corp.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ARTIFICIAL ORGANS
8.1 Industry Chain of Artificial Organs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ARTIFICIAL ORGANS
9.1 Cost Structure Analysis of Artificial Organs
9.2 Raw Materials Cost Analysis of Artificial Organs
9.3 Labor Cost Analysis of Artificial Organs
9.4 Manufacturing Expenses Analysis of Artificial Organs
CHAPTER 10 MARKETING STATUS ANALYSIS OF ARTIFICIAL ORGANS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Artificial Organs in This Report
1.2 Commercial Types of Artificial Organs
1.2.1 Artificial Heart
1.2.2 Artificial Liver
1.2.3 Artificial Pancreas
1.2.4 Artificial Lungs
1.2.5 Artificial Kidney
1.2.6 Other
1.3 Downstream Application of Artificial Organs
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Other
1.4 Development History of Artificial Organs
1.5 Market Status and Trend of Artificial Organs 2013-2023
1.5.1 United States Artificial Organs Market Status and Trend 2013-2023
1.5.2 Regional Artificial Organs Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Artificial Organs in United States 2013-2017
2.2 Consumption Market of Artificial Organs in United States by Regions
2.2.1 Consumption Volume of Artificial Organs in United States by Regions
2.2.2 Revenue of Artificial Organs in United States by Regions
2.3 Market Analysis of Artificial Organs in United States by Regions
2.3.1 Market Analysis of Artificial Organs in New England 2013-2017
2.3.2 Market Analysis of Artificial Organs in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Artificial Organs in The Midwest 2013-2017
2.3.4 Market Analysis of Artificial Organs in The West 2013-2017
2.3.5 Market Analysis of Artificial Organs in The South 2013-2017
2.3.6 Market Analysis of Artificial Organs in Southwest 2013-2017
2.4 Market Development Forecast of Artificial Organs in United States 2018-2023
2.4.1 Market Development Forecast of Artificial Organs in United States 2018-2023
2.4.2 Market Development Forecast of Artificial Organs by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Artificial Organs in United States by Types
3.1.2 Revenue of Artificial Organs in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Artificial Organs in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Artificial Organs in United States by Downstream Industry
4.2 Demand Volume of Artificial Organs by Downstream Industry in Major Countries
4.2.1 Demand Volume of Artificial Organs by Downstream Industry in New England
4.2.2 Demand Volume of Artificial Organs by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Artificial Organs by Downstream Industry in The Midwest
4.2.4 Demand Volume of Artificial Organs by Downstream Industry in The West
4.2.5 Demand Volume of Artificial Organs by Downstream Industry in The South
4.2.6 Demand Volume of Artificial Organs by Downstream Industry in Southwest
4.3 Market Forecast of Artificial Organs in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ARTIFICIAL ORGANS
5.1 United States Economy Situation and Trend Overview
5.2 Artificial Organs Downstream Industry Situation and Trend Overview
CHAPTER 6 ARTIFICIAL ORGANS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Artificial Organs in United States by Major Players
6.2 Revenue of Artificial Organs in United States by Major Players
6.3 Basic Information of Artificial Organs by Major Players
6.3.1 Headquarters Location and Established Time of Artificial Organs Major Players
6.3.2 Employees and Revenue Level of Artificial Organs Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ARTIFICIAL ORGANS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Diabetes Care, Inc.
7.1.1 Company profile
7.1.2 Representative Artificial Organs Product
7.1.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Abbott Diabetes Care, Inc.
7.2 Abiomed, Inc.
7.2.1 Company profile
7.2.2 Representative Artificial Organs Product
7.2.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Abiomed, Inc.
7.3 Asahi Kasei Medical Co., Ltd.
7.3.1 Company profile
7.3.2 Representative Artificial Organs Product
7.3.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Asahi Kasei Medical Co., Ltd.
7.4 Baxter International, Inc.
7.4.1 Company profile
7.4.2 Representative Artificial Organs Product
7.4.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Baxter International, Inc.
7.5 F.Hoffmann-La Roche Ltd.
7.5.1 Company profile
7.5.2 Representative Artificial Organs Product
7.5.3 Artificial Organs Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche Ltd.
7.6 Fresenius Medical Care AG & Co. KGaA
7.6.1 Company profile
7.6.2 Representative Artificial Organs Product
7.6.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Fresenius Medical Care AG & Co. KGaA
7.7 HeartWare International, Inc.
7.7.1 Company profile
7.7.2 Representative Artificial Organs Product
7.7.3 Artificial Organs Sales, Revenue, Price and Gross Margin of HeartWare International, Inc.
7.8 Jarvik Heart, Inc.
7.8.1 Company profile
7.8.2 Representative Artificial Organs Product
7.8.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Jarvik Heart, Inc.
7.9 Medtronic, Inc.
7.9.1 Company profile
7.9.2 Representative Artificial Organs Product
7.9.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Medtronic, Inc.
7.10 Nikkiso Co., Ltd.
7.10.1 Company profile
7.10.2 Representative Artificial Organs Product
7.10.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Nikkiso Co., Ltd.
7.11 Nipro Corporation
7.11.1 Company profile
7.11.2 Representative Artificial Organs Product
7.11.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Nipro Corporation
7.12 SynCardia Systems, Inc.
7.12.1 Company profile
7.12.2 Representative Artificial Organs Product
7.12.3 Artificial Organs Sales, Revenue, Price and Gross Margin of SynCardia Systems, Inc.
7.13 Terumo Heart, Inc.
7.13.1 Company profile
7.13.2 Representative Artificial Organs Product
7.13.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Terumo Heart, Inc.
7.14 Thoratec Corp.
7.14.1 Company profile
7.14.2 Representative Artificial Organs Product
7.14.3 Artificial Organs Sales, Revenue, Price and Gross Margin of Thoratec Corp.
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ARTIFICIAL ORGANS
8.1 Industry Chain of Artificial Organs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ARTIFICIAL ORGANS
9.1 Cost Structure Analysis of Artificial Organs
9.2 Raw Materials Cost Analysis of Artificial Organs
9.3 Labor Cost Analysis of Artificial Organs
9.4 Manufacturing Expenses Analysis of Artificial Organs
CHAPTER 10 MARKETING STATUS ANALYSIS OF ARTIFICIAL ORGANS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
